Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Breaking & Recent News Conformis Inc. CFMS

Conformis Inc is an us-based medical technology company. It uses the iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants that are individually sized and shaped to fit each patient's anatomy. The company's iFit technology platform comprises three key elements which are iFit design, iFit printing, and iFit just-in-time delivery. It offers various partial and total knee replacement implants which include iTotal CR, iTotal PS, iDuo, and iUni. The company operates in the segment of the knee replacement market. Its total revenue is generated from the sale of its products to hospitals and other medical facilities. The majority of the company's revenue comes from the United States.


Recent & Breaking News (NDAQ:CFMS)

Conformis Announces Return to Work of Furloughed Employees

GlobeNewswire April 23, 2020

Conformis Receives $4.7 Million under the Paycheck Protection Program

GlobeNewswire April 20, 2020

Conformis to Hold Virtual Annual Meeting of Stockholders on April 27, 2020

GlobeNewswire April 9, 2020

Conformis Announces Actions to Mitigate COVID-19 Impact

GlobeNewswire March 23, 2020

Conformis Reports Fourth Quarter and Year End 2019 Financial Results

GlobeNewswire March 2, 2020

Conformis, Inc. to Present at the Cowen 40th Annual Health Care Conference

GlobeNewswire February 21, 2020

Conformis to Host Fourth Quarter and Fiscal Year 2019 Financial Results Webcast on March 2, 2020

GlobeNewswire February 20, 2020

Conformis iTotal® CR Knee Replacement System Awarded "5A" Rating from the Orthopaedic Data Evaluation Panel in the United Kingdom

GlobeNewswire February 19, 2020

Conformis Appoints Bob Howe as Chief Financial Officer

GlobeNewswire February 5, 2020

Conformis Achieves 100,000 Implant Milestone for Patient-Specific Knee Replacement Technology

GlobeNewswire January 30, 2020

Conformis Reports Preliminary Fourth Quarter and Year-End 2019 Revenue Results

GlobeNewswire January 14, 2020

Conformis Announces FDA Clearance and Full Commercial Launch of Next Generation Hip System at the 2019 AAHKS Conference

GlobeNewswire November 7, 2019

Conformis Reports Third Quarter 2019 Financial Results

GlobeNewswire October 30, 2019

Conformis to Host Third Quarter 2019 Financial Results Webcast on October 30, 2019

GlobeNewswire October 15, 2019

Conformis Announces Departure of Paul Weiner, CFO

GlobeNewswire October 4, 2019

Conformis and Stryker Execute Development, License and Distribution Agreements

GlobeNewswire October 1, 2019

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Conformis, Inc. - CFMS

Press Releases August 7, 2019

Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Conformis, Inc. (CFMS)

PR Newswire August 6, 2019

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Conformis, Inc. - CFMS

GlobeNewswire August 1, 2019

Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Conformis, Inc. (CFMS)

Press Releases August 1, 2019